FDA Inspection 1166570 — Zeigler Brothers, Inc.
The FDA completed an inspection of Zeigler Brothers, Inc. on April 6, 2022 in East Berlin, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 6, 2022
- Fiscal Year
- 2022
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- East Berlin, PA (United States)